Glenmede Trust’s Equifax EFX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.46M Buy
13,647
+102
+0.8% +$20.3K 0.01% 538
2025
Q4
$2.94M Buy
+13,545
New +$2.97M 0.01% 509
2025
Q1
$3.21M Buy
13,161
+245
+2% +$61.6K 0.02% 483
2024
Q4
$3.29M Sell
12,916
-46,481
-78% -$12.5M 0.02% 466
2024
Q3
$17.5M Sell
59,397
-9
-0% -$2.54K 0.08% 246
2024
Q2
$14.4M Buy
59,406
+259
+0.4% +$61.8K 0.07% 278
2024
Q1
$15.8M Sell
59,147
-2,098
-3% -$534K 0.08% 263
2023
Q4
$15.1M Buy
61,245
+183
+0.3% +$37.1K 0.08% 257
2023
Q3
$11.2M Buy
61,062
+4,856
+9% +$991K 0.06% 314
2023
Q2
$11.4M Hold
56,206
0.06% 313
2023
Q1
$11.4M Buy
56,206
+56
+0.1% +$11.7K 0.06% 313
2022
Q4
$10.9M Buy
56,150
+2,591
+5% +$474K 0.06% 316
2022
Q3
$9.18M Sell
53,559
-1,804
-3% -$353K 0.06% 338
2022
Q2
$10.1M Buy
55,363
+1,103
+2% +$221K 0.06% 345
2022
Q1
$12.9M Buy
54,260
+761
+1% +$179K 0.06% 340
2021
Q4
$15.7M Sell
53,499
-45
-0.1% -$12.5K 0.07% 305
2021
Q3
$13.6M Sell
53,544
-285
-0.5% -$74.1K 0.07% 308
2021
Q2
$12.9M Buy
53,829
+2,258
+4% +$505K 0.07% 315
2021
Q1
$9.34M Buy
51,571
+2,479
+5% +$438K 0.05% 338
2020
Q4
$9.47M Buy
49,092
+208
+0.4% +$35K 0.05% 327
2020
Q3
$7.67M Buy
48,884
+1,474
+3% +$241K 0.05% 336
2020
Q2
$8.15M Buy
47,410
+671
+1% +$99.4K 0.05% 334
2020
Q1
$6.55M Hold
46,739
0.03% 415
2019
Q4
$6.55M Buy
46,739
+247
+0.5% +$34.2K 0.03% 415
2019
Q3
$6.54K Sell
46,492
-30,028
-39% -$4.23M 0.03% 403
2019
Q2
$10.3K Buy
76,520
+235
+0.3% +$29.5K 0.05% 368
2019
Q1
$9.04K Sell
76,285
-3,827
-5% -$409K 0.04% 385
2018
Q4
$7.46K Buy
80,112
+410
+0.5% +$43.6K 0.04% 386
2018
Q3
$10.4M Sell
79,702
-498
-0.6% -$64.9K 0.04% 375
2018
Q2
$10M Sell
80,200
-2,919
-4% -$346K 0.04% 358
2018
Q1
$9.8M Hold
83,119
0.04% 373
2017
Q4
$9.8M Sell
83,119
-164
-0.2% -$18.4K 0.04% 373
2017
Q3
$8.83M Sell
83,283
-171,813
-67% -$22.7M 0.04% 378
2017
Q2
$34.9M Hold
255,096
0.17% 193
2017
Q1
$34.9M Buy
255,096
+20
+0% +$2.54K 0.17% 193
2016
Q4
$30.2M Sell
255,076
-2,615
-1% -$320K 0.16% 220
2016
Q3
$34.7M Buy
257,691
+123,915
+93% +$16.4M 0.2% 160
2016
Q2
$17.2M Buy
133,776
+14,111
+12% +$1.71M 0.1% 293
2016
Q1
$13.7M Buy
119,665
+93,354
+355% +$9.82M 0.09% 310
2015
Q4
$2.93M Buy
26,311
+50
+0.2% +$5.4K 0.02% 525
2015
Q3
$2.55M Buy
26,261
+9,927
+61% +$986K 0.02% 543
2015
Q2
$1.58M Buy
16,334
+9,300
+132% +$907K 0.01% 657
2015
Q1
$654K Sell
7,034
-83,650
-92% -$7.42M ﹤0.01% 866
2014
Q4
$7.33M Sell
90,684
-1,590
-2% -$123K 0.06% 388
2014
Q3
$6.9M Sell
92,274
-2,586
-3% -$197K 0.06% 372
2014
Q2
$6.88M Buy
94,860
+10
+0% +$702 0.06% 366
2014
Q1
$6.45M Buy
94,850
+2,700
+3% +$189K 0.06% 372
2013
Q4
$6.37M Sell
92,150
-750
-0.8% -$48.8K 0.07% 348
2013
Q3
$5.56M Sell
92,900
-64,180
-41% -$3.95M 0.07% 336
2013
Q2
$9.25M Buy
+157,080
New +$9.48M 0.12% 192

Other funds holding EFX

Glenmede Trust's EFX Position: Q1 2026 in Review

Glenmede Trust increased its Equifax (EFX) stake by 0.75% in Q1 2026, buying an estimated $20.3K and bringing the position to 13,647 shares worth $2.46M. The position accounts for 0.01% of the portfolio, ranked #538.

Glenmede Trust first reported a position in EFX in Q2 2013 and has held it in 50 quarters since. The position peaked at $34.9M in Q2 2017. 870 funds tracked by Wall St. Rank hold EFX as of Q1 2026.

  • Glenmede Trust held 13,647 shares of Equifax worth $2.46M as of Q1 2026.
  • Glenmede Trust bought 102 Equifax shares in Q1 2026, an estimated $20.3K.
  • Equifax made up 0.01% of Glenmede Trust's portfolio in Q1 2026, its #538 holding.
  • Glenmede Trust first reported a position in Equifax in Q2 2013 and has held it in 50 quarters since.
  • Glenmede Trust's Equifax position peaked at $34.9M in Q2 2017.
  • 870 funds tracked by Wall St. Rank held Equifax as of Q1 2026.

Based on Glenmede Trust's 13F filing for Q1 2026, filed 26 May 2026.